Oleg Y. Narusov

Moscow, MOW, Russian Federation

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Patient selection for left ventricular assist device implantation. The main problems

Patient selection for left ventricular assist device implantation. The main problems

Journal: Terapevticheskii arkhiv
Published: February 15, 2024

The Effectiveness of Outpatient Treatment Under the Control of the Soluble ST2 Receptor Concentration in Patients With Heart Failure With Reduced Ejection Fraction After Acute Decompensation of Heart Failure.

The Effectiveness of Outpatient Treatment Under the Control of the Soluble ST2 Receptor Concentration in Patients With Heart Failure With Reduced Ejection Fraction After Acute Decompensation of Heart Failure.

Journal: Kardiologiia
Published: November 15, 2022

Implication of inflammation on Coxsackie virus and Adenovirus receptor expression on cardiomyocytes and the role of platelets in patients with dilated cardiomyopathy.

Implication of inflammation on Coxsackie virus and Adenovirus receptor expression on cardiomyocytes and the role of platelets in patients with dilated cardiomyopathy.

Journal: Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology
Published: April 19, 2022

Experience of complex application of cardiac contractility modulation by Optimizer Smart System and endovascular mitral valve repair by the MitraClip System in the treatment of heart failure

Experience of complex application of cardiac contractility modulation by Optimizer Smart System and endovascular mitral valve repair by the MitraClip System in the treatment of heart failure

Journal: Kardiologiia
Published: March 31, 2021

Soluble ST2 - biomarker for prognosis and monitoring in decompensated heart failure

Soluble ST2 - biomarker for prognosis and monitoring in decompensated heart failure

Journal: Kardiologiia
Published: July 25, 2019

The value of cardiovascular magnetic resonance in myocarditis with different clinical presentation.

The value of cardiovascular magnetic resonance in myocarditis with different clinical presentation.

Journal: Terapevticheskii arkhiv
Published: May 17, 2019

Title Not Found

Title Not Found

Journal: Kardiologiia
Published: January 31, 2019

Title Not Found

Title Not Found

Journal: Kardiologiia
Published: December 26, 2018

Head to Head Comparison of Suppression of Tumorogenicity 2 and Copeptin Significance for Prognosis of Patients After Acute Heart Failure Decompensation.

Head to Head Comparison of Suppression of Tumorogenicity 2 and Copeptin Significance for Prognosis of Patients After Acute Heart Failure Decompensation.

Journal: Kardiologiia
Published: November 17, 2018

Head to Head Comparison of Suppression of Tumorogenicity 2 and Copeptin Significance for Prognosis of Patients After Acute Heart Failure Decompensation

Head to Head Comparison of Suppression of Tumorogenicity 2 and Copeptin Significance for Prognosis of Patients After Acute Heart Failure Decompensation

Journal: Kardiologiia
Published: February 22, 2018

Therapy of High Risk Patients After Decompensation of Heart Failure Under NT-proBNP Control. Main Results

Therapy of High Risk Patients After Decompensation of Heart Failure Under NT-proBNP Control. Main Results

Journal: Kardiologiia
Published: March 15, 2017

Soluble Suppression of Tumorogenicity 2 Increases Opportunities for Risk Stratification After Acute Heart Failure Decompensation

Soluble Suppression of Tumorogenicity 2 Increases Opportunities for Risk Stratification After Acute Heart Failure Decompensation

Journal: Kardiologiia
Published: March 15, 2017
Showing 1-12 of 13

Last Updated: 09/26/2026